FDA to set up new Office of the Chief Medical Officer as part of agency reshuffling
The FDA is working to establish a new office — dubbed the Office of the Chief Medical Officer — to coordinate cross-agency operations amid the agency’s …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
